Status:
COMPLETED
Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Lead Sponsor:
Samsung Medical Center
Conditions:
Benign Prostatic Hyperplasia (BPH)
Eligibility:
MALE
Brief Summary
Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate
Eligibility Criteria
Inclusion
- Male patient scheduled to undergo prostatectomy using holmium laser
Exclusion
- Urethral stricture, large bladder diverticulum, bladder neck contracture
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 28 2019
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT03460873
Start Date
September 1 2015
End Date
November 28 2019
Last Update
December 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, South Korea, 135-710